Top Small-Cap Stocks to Watch

$SANM — Sanmina

Sanmina is a global electronics manufacturing and supply-chain solutions provider serving cloud infrastructure, communications, industrial and medical customers. Its growth profile has strengthened significantly following the ZT Systems transaction and rising demand from AI and data-center infrastructure. Fiscal Q3 revenue reached $3.46 billion, while non-GAAP EPS rose to $3.31, both ahead of management expectations. Sanmina also raised its FY2026 revenue and EPS outlook, citing stronger orders across both its core business and ZT Systems. With demand expected to remain strong into FY2027 and FY2028, Sanmina offers relatively direct exposure to expanding AI hardware investment backed by improving earnings and cash generation.

$CORT — Corcept Therapeutics

Corcept Therapeutics develops therapies that regulate the effects of cortisol, with commercial exposure to endocrinology and oncology. The company is benefiting from strong growth in its Cushing’s syndrome franchise while expanding beyond its established Korlym business. Second-quarter revenue increased 32% year over year to $256.1 million, driven by both Korlym and the newer Lifyorli product, prompting management to raise 2026 revenue guidance to $1.1–$1.2 billion. Corcept also remains highly cash generative, with more than $540 million in cash and investments. Its combination of accelerating product revenue, pipeline optionality and a relatively specialized therapeutic focus provides a strong fundamental growth profile.

$CRS — Carpenter Technology

Carpenter Technology produces high-performance specialty alloys and engineered materials used primarily in aerospace, defense, medical and power-generation applications. The company is benefiting from sustained aerospace production growth and tight supply for technically demanding materials. Fiscal 2026 was the most profitable year in Carpenter’s history, with adjusted operating income rising 34% to $702 million and adjusted free cash flow reaching $362 million. Aerospace and defense sales excluding surcharges grew 15%, while management expects FY2027 operating income to rise another 21–25% to $850–$880 million. Strong pricing, improving product mix and additional capacity should support further earnings and cash-flow expansion.